Front Opens in War on Drug Prices as Biotech Sinks

Dec 23, 2014, 00:00 by Michael Croft

Bloomberg | The biotechnology industry's two-year run of riches is at risk after a decision by the biggest U.S. drug manager to block one of the best-selling products in history.

December 23, 2014 | The biotechnology industry's two-year run of riches is at risk after a decision by the biggest U.S. drug manager to block one of the best-selling products in history. Bloomberg